Newsroom
Client news
The latest news from Optimum clients
Optimum’s EU Life Science Investor Survey 2025
Download for direct insights from leading European investors
Weekly wrap-up
Read Optimum’s round-up for the low-down on client and industry news
Current public market environment and equity investor views
/in InsightsBiotech is “hot” and M&A deals are likely to be an ongoing feature of the industry
/in InsightsScaling up a Company to $10bn-$20bn
/in Insights